Evotec SE (EVO)
| Bid | 3.38 |
| Market Cap | 1.24B |
| Revenue (ttm) | 777.33M |
| Net Income (ttm) | -155.53M |
| EPS (ttm) | -0.52 |
| PE Ratio (ttm) | -6.69 |
| Forward PE | -42.12 |
| Analyst | Hold |
| Ask | 3.65 |
| Volume | 84,502 |
| Avg. Volume (20D) | 81,229 |
| Open | 3.46 |
| Previous Close | 3.37 |
| Day's Range | 3.44 - 3.52 |
| 52-Week Range | 2.84 - 5.64 |
| Beta | 1.06 |
Analyst Forecast
According to 0 analyst ratings, the average rating for EVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · accessnewswire.com
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy ExecutionStrategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductions Reporting segment formerly known as Shared R&D renamed to Discovery & Pre...
1 month ago · accessnewswire.com
Evotec SE to announce first half-year results 2025 on 13 August 2025HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its half-year interim r...
1 month ago · accessnewswire.com
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse SiteHAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-bin...
1 month ago · accessnewswire.com
Evotec SE Adjusts Revenue Guidance while Confirming Profit GuidanceHAMBURG, DE / ACCESS Newswire / July 21, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its ...
